Bioptimus is a Biotech company based in Paris, France. It has raised $35M in total funding. Latest round: Seed.
Bioptimus funding overview
Bioptimus is a Biotech company based in Paris, France. Bioptimus has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in February 2024. The round record for Bioptimus runs through 2024; nothing later has been disclosed. Investors on record include Sofinnova Partners, Bpifrance Large Venture, Frst, Cathay Innovation, Headline, Hummingbird and 4 others. 10 distinct backers are named across the disclosed rounds.
Bioptimus has raised $35M in total disclosed funding across the rounds on record.
Who has invested in Bioptimus?
Sofinnova Partners, Bpifrance Large Venture, Frst, Cathay Innovation, Headline, Hummingbird are named among the investors backing Bioptimus.
What was the latest Bioptimus funding round?
The most recent disclosed round is a Seed, announced in February 2024.
Where is Bioptimus based?
Bioptimus is based in Paris, France.
What sector does Bioptimus operate in?
Bioptimus is tracked under Biotech from Paris, France, with $35M in disclosed funding.
When did Bioptimus last raise?
The last disclosed Bioptimus round closed in February 2024 at Seed.
Round data for Bioptimus is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Paris and backer lists below.
